Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
ADEPT
2 other identifiers
interventional
150
1 country
1
Brief Summary
The proposed randomized controlled trial will test the effect of a low-carbohydrate diet on hemoglobin A1c among individuals with elevated hemoglobin A1c that are within the range of prediabetes or diabetes. Results may provide evidence about the role of carbohydrate restriction in individuals with or at high risk of type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Sep 2018
Typical duration for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2018
CompletedFirst Posted
Study publicly available on registry
September 18, 2018
CompletedStudy Start
First participant enrolled
September 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2021
CompletedResults Posted
Study results publicly available
March 1, 2023
CompletedMarch 1, 2023
January 1, 2023
2.7 years
September 14, 2018
November 28, 2022
January 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Hemoglobin A1c
6-month change in Hemoglobin A1c comparing low-carbohydrate arm with usual diet arm
Baseline and six months
Secondary Outcomes (4)
Change in Fasting Plasma Glucose
Baseline and six months
Change in Systolic Blood Pressure
Baseline and six months
Change in Total-to-HDL-cholesterol Ratio
Baseline and six months
Change in Body Weight
Baseline and six months
Other Outcomes (5)
Change in Insulin
Baseline and six months
Change in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
Baseline and six months
Change in Diastolic Blood Pressure
Baseline and six months
- +2 more other outcomes
Study Arms (2)
Low-Carbohydrate Diet
EXPERIMENTALBehavioral modification to reduce carbohydrate consumption. Target \<40 g net carbohydrates per day for first 3 months; \<60 g net carbohydrates per day for months 4 onwards. The intervention will consist of 4 weekly individual counseling sessions, followed by 4 group sessions held every other week, with phone follow-ups in between group sessions. For the last 3 months of the study, there will be 3 monthly group sessions and 3 telephone follow-ups. At baseline, participants will receive written information with standard physical activity recommendations.
Usual Diet
NO INTERVENTIONNo dietary intervention. At baseline, participants will receive written information with standard dietary advice and standard physical activity recommendations.
Interventions
Behavioral modification to reduce carbohydrate consumption. Target \<40 g net carbohydrates per day for first 3 months; \<60 g net carbohydrates per day for months 4 onwards. The intervention will consist of 4 weekly individual counseling sessions, followed by 4 group sessions held every other week, with phone follow-ups in between group sessions. For the last 3 months of the study, there will be 3 monthly group sessions and 3 telephone follow-ups. At baseline, participants will receive written information with standard physical activity recommendations.
Eligibility Criteria
You may qualify if:
- Men or women ages 40 to 70 years
- HbA1c 6.0-6.9%
- Willing and able to provide informed consent
You may not qualify if:
- Diagnosed type 1 diabetes mellitus
- Use of agents affecting glycemic control (medications for diabetes, oral glucocorticoids) within the past three months prior to enrollment
- Medical condition in which low-carbohydrate diet may not be advised: estimated glomerular filtration rate (eGFR) ≤45 mL/min/1.73 m²; self-report of liver disease due to hepatitis or alcohol; osteoporosis; untreated thyroid disease; gout; cancer (other than non-melanoma skin cancer) requiring treatment in the past year, unless prognosis is excellent
- Factors that may affect HbA1c: hemoglobin \<11 mg/dL (cutpoint for moderate-to-severe anemia, which could lead to falsely elevated or lowered HbA1c); recent blood donation or blood transfusion (self-report, past 4 months); human immunodeficiency virus (self-report)
- Self-reported history of intensive care unit stay due to Coronavirus Disease 2019 (COVID-19) in the past three months, as severe COVID-19 may affect blood glucose levels
- Allergies to nuts
- For women, current pregnancy, breastfeeding, or plans to become pregnant during the study
- Consumption of ≥21 alcoholic drinks per week or consumption of ≥6 drinks per occasion
- Current or planned residence making it difficult to meet trial requirements (due to distance from study site and/or challenges regularly traveling to site)
- Current participation in another lifestyle intervention trial or a pharmaceutical trial
- Participation of another household member in the study; employees or persons living with employees of the study
- Other concerns regarding ability to meet trial requirements, at the discretion of the principal investigator or study coordinator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tulane Office of Health Research
New Orleans, Louisiana, 70112, United States
Related Publications (2)
Dorans KS, Bazzano LA, Qi L, He H, Chen J, Appel LJ, Chen CS, Hsieh MH, Hu FB, Mills KT, Nguyen BT, O'Brien MJ, Samet JM, Uwaifo GI, He J. Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial. JAMA Netw Open. 2022 Oct 3;5(10):e2238645. doi: 10.1001/jamanetworkopen.2022.38645.
PMID: 36287562DERIVEDDorans KS, Bazzano LA, Qi L, He H, Appel LJ, Samet JM, Chen J, Mills KT, Nguyen BT, O'Brien MJ, Uwaifo GI, He J. Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial. Trials. 2021 Feb 1;22(1):108. doi: 10.1186/s13063-020-05001-x.
PMID: 33522954DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology
- Organization
- Tulane University School of Public Health and Tropical Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten Dorans, ScD
Tulane University School of Public Health and Tropical Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 14, 2018
First Posted
September 18, 2018
Study Start
September 25, 2018
Primary Completion
June 21, 2021
Study Completion
June 21, 2021
Last Updated
March 1, 2023
Results First Posted
March 1, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share